Pillstats
Rx only · Solution · Intravenous

Eribulin Mesylate

Eribulin Mesylate

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US3 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)1045453
US makers3 labelers
Packages3
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1352694045382025 Q12025 Q22025 Q32025 Q42026 Q1
343
Rx · 2026 Q1
1.1K
Units dispensed
+14%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
NorthStar Rx LLCunknown1SUPPLYING
Long Grove Pharmaceuticals, LLCunknown1SUPPLYING
BluePoint Laboratoriesunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.